C-reactive protein at pembrolizumab initiation and its trajectory from first-line chemotherapy as prognostic markers in metastatic urothelial carcinoma (YUSHIMA study).
来源：PubMed发布日期：2026-08-07作者：Yajima S, Yoshida S, Sato H, Hirakawa A, Fukushima H0 次点击